Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $3.1 down -2.52% from its previous closing price of $3.18. In other words, the price has decreased by -$2.52 from its previous closing price. On the day, 2.05 million shares were traded. RCKT stock price reached its highest trading level at $3.245 during the session, while it also had its lowest trading level at $3.085.
Ratios:
For a deeper understanding of Rocket Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On July 25, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $4. Evercore ISI Downgraded its Outperform to In-line on May 30, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 27 ’25 when Bjork Elisabeth bought 10,000 shares for $3.41 per share. The transaction valued at 34,100 led to the insider holds 40,000 shares of the business.
Militello John sold 699 shares of RCKT for $2,142 on Aug 18 ’25. The insider now owns 56,285 shares after completing the transaction at $3.06 per share. On Aug 19 ’25, another insider, Militello John, who serves as the insider of the company, sold 361 shares for $3.00 each. As a result, the insider received 1,082 and left with 55,924 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 334501984 and an Enterprise Value of 88210000.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.59, which has changed by -0.83206934 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $20.31, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is -2.37%, while the 200-Day Moving Average is calculated to be -53.31%.
Shares Statistics:
For the past three months, RCKT has traded an average of 3.89M shares per day and 2146160 over the past ten days. A total of 107.88M shares are outstanding, with a floating share count of 98.68M. Insiders hold about 8.55% of the company’s shares, while institutions hold 84.72% stake in the company. Shares short for RCKT as of 1756425600 were 15488041 with a Short Ratio of 3.98, compared to 1753920000 on 11233730. Therefore, it implies a Short% of Shares Outstanding of 15488041 and a Short% of Float of 27.950000000000003.
Earnings Estimates
Its stock is currently analyzed by 14.0 different market analysts. The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.33 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.69 and -$2.36 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$1.19, with 13.0 analysts recommending between $0.69 and -$2.13.
